Table 1.

Demographics, injury severity, and outcomes by coagulopathy

Median (IQR)	ATC N=439 (23%)	NON-ATC N=1438 (77%)	p
Age	38 (22–57)	43 (28–55)	<0.01*
Gender (% male)	66.3	66.6	0.95
ISS	38 (27–50)	29 (22–41)	<0.01*
APACHE II	32 (28–36)	28 (24–33)	<0.01*
Initial base deficit	9.7 (6.8–13.1)	7.6 (5.3–10.9)	<0.01*
INR	1.9 (1.7–2.3)	1.2 (1.1–1.3)	<0.01*
24hr blood requirement	10.5 (5.7–18.7)	5 (2.7–9.33)	<0.01*
24hr FFP requirement	7.2 (3.5–11.8)	1.6 (0–4.8)	<0.01*
24hr platelet requirement	0.9 (0–1.8)	0 (0–0.9)	<0.01*
24hr crystalloid requirement	14.9 (10.4–20.8)	12.2 (8.9–16.6)	<0.01*
Massive transfusion (%)	52.2	23.4	<0.01*
Early surgery (%)	53.5	40.8	<0.01*
Coumadin (%)	6.2	0.6	<0.01*
ICU days	9 (4–17)	12 (5–19)	<0.01*
In-hospital mortality (%)	26.2	11.4	<0.01*
MOF (%)	38.7	27.7	<0.01*

^*p < 0.05